Use of ADHD medication during pregnancy from 1999 to 2010: A Danish register-based study

Pharmacoepidemiology and Drug Safety

Volumn 23, Issue 5, 2014, Pages 526-533

  Hærvig, Katia Buch ^a   Mortensen, Laust Hvas ^a   Hansen, Anne Vinkel ^a   Strandberg Larsen, Katrine ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

ADHD; ADHD medication; Attention deficit hyperactivity disorder; Pharmacoepidemiology; Pregnancy; Pregnancy outcome; Psychostimulants

Indexed keywords

ATOMOXETINE; METHYLPHENIDATE; MODAFINIL;

ADOLESCENT; ADULT; ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG EXPOSURE; DRUG SAFETY; DRUG USE; FEMALE; HUMAN; INCIDENCE; INDUCED ABORTION; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PREGNANCY; PREGNANCY OUTCOME; PRESCRIPTION; PRIORITY JOURNAL; SOCIAL SECURITY; SPONTANEOUS ABORTION; ABORTION, SPONTANEOUS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COMPLICATION; DENMARK; MIDDLE AGED; PREGNANCY COMPLICATIONS; REGISTER; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ABORTION, INDUCED; ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DENMARK; FEMALE; HUMANS; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; REGISTRIES; YOUNG ADULT;

EID: 84898029208     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3600     Document Type: Article

References (25)

1. Pottegård A, Bjerregaard BK, Glintborg D, Kortegaard LS, Hallas J, Moreno SI. The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective. Eur J Clin Pharmacol 2013; 69(3): 589-598.
2. Pottegård A, Bjerregaard BK, Glintborg D, Hallas J, Moreno SI. The use of medication against attention deficit hyperactivity disorder in Denmark: a drug use study from a national perspective. Eur J Clin Pharmacol 2012; 68(10): 1443-1450.
3. Zoëga H, Furu K, Halldórsson M, Thomsen PH, Sourander A, Martikainen JE. Use of ADHD drugs in the Nordic countries: a population-based comparison study. Acta Psychiatr Scand 2011; 123(5): 360-367.
4. Dideriksen D, Pottegård A, Hallas J, Aagaard L, Damkier P. First trimester in utero exposure to methylphenidate. Basic Clin Pharmacol 2013; 112(2): 73-76.
5. Humphreys C, Garcia-Bounissen F, Ito S, Koren G. Motherisk Update Exposure to attention de cit hyperactivity disorder medications during pregnancy. Can Fam Physician 2007; 53: 1153-1155.
6. Ashton H, Gallagher P, Moore B. The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder. J Psychopharmacol 2006; 20(5): 602-610.
7. Ryan L, Ehrlich S, Finnegan L. Cocaine abuse in pregnancy: effects on the fetus and newborn. Neurotoxicol Teratol 1987; 9(4): 295-299.
8. Sithisarn T, Granger D, Bada H. Consequences of prenatal substance use. Int J Adolesc Med Health 2012; 24(2): 105-112.
9. Bolea-Alamanac BM, Green A, Verma G, Maxwell P, Davies SJC. Methylphenidate use in pregnancy and lactation, a systematic review of evidence. Br J Clin Pharmacol [Internet] 2013 [cited 2013 Nov 26]; 1-20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23593966
10. Pedersen CB. The Danish Civil Registration System. Scand J Public Health 2011; 39(7 Suppl): 22-25.
11. Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health 2011; 39(7 Suppl): 38-41.
12. Mors O, Perto GP, Mortensen PB. The Danish Psychiatric Central Research Register. Scand J Public Health 2011; 39(7 Suppl): 54-57.
13. WHO. WHO Collaboration Centre for Drug Statistics Methodology [Internet]. 2012 [cited 2013 Apr 23]. Available from: http://www.whocc.no
14. Statistics Denmark. Immigrants and decendants [Indvandre og efterkommere] [Internet]. [cited 2013 Mar 11]. Available from: http://www.dst.dk/da/Statistik/emner/indvandrere-og-efterkommere/indvandrere-og-efterkommere.aspx
15. Law. The Danish health law [Internet]. 2010 [cited 2013 Nov 26]. p. 140. Available from: https://www.retsinformation.dk/forms/r0710.aspx?id=130455#K26
16. Center for Disease Control [Statens Serum Institut]. SSI Statistics: medstat.dk [Internet]. 2013 [cited 2013 Mar 14]. Available from: http://medstat.dk/
17. Maclure M, Mittleman M. Should we use a case-crossover design? Annu Rev Public Health 2000; 21: 193-221.
18. Castle L, Aubert RE, Verbrugge RR, Khalid M, Epstein RS. Trends in medication treatment for ADHD. J Atten Disord 2007; 10(4): 335-342.
19. The National Board of Health [Sundhedsstyrelsen]. The sale of ADHD drugs from 2002-2011 in Denmark [Salget af ADHD-medicin fra 2002-2011]. 2011;1-6. Available from: http://www.ssi.dk/Sundhedsdataogit/Analyser og rapporter/Lagemiddelforbrugsanalyser/2012/~/media/Indhold/DK-dansk/Sundhedsdata og it/NSF/Analyser og rapporter/Laegemiddelforbrugsanalyser/2012/Salget af ADHD medicin fra 2002-2011.ashx
20. Danish Health and Medicines Authority. Registred medicine in Denmark [Internet]. 2012 [cited 2013 Nov 26]. Available from: http://sundhedsstyrelsen.dk/da/medicin/regulering/godkendelse-af-medicin/lister-over-godkendte-og-afregistrerede-laegemidler
21. Mao AR, Babcock T, Brams M. ADHD in adults: current treatment trends with consideration of abuse potential of medications. J Psychiatr Pract 2011; 17(4): 241-250.
22. Lensing MB, Zeiner P, Sandvik L, Opjordsmoen S. Four-year outcome in psychopharmacologically treated adults with attention-deficit/hyperactivity disorder: a questionnaire survey. J Clin Psychiatry 2013; 74(1): e87-e93.
23. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006; 163(4): 716-723.
24. Lichtenstein P, Halldner L, Zetterqvist J, Sjölander A, et al. Medication for attention deficit-hyperactivity disorder and criminality. N Engl J Med 2012; 367(21): 2006-2014.
25. Grzeskowiak LE, Gilbert AL, Morrison JL. Exposed or not exposed? Exploring exposure classification in studies using administrative data to investigate outcomes following medication use during pregnancy. Eur J Clin Pharmacol 2012; 68(5): 459-467.